Abstract:Abstract Background Lovastatin has widespread applications thanks to its multiple pharmacological effects. Fermentation by filamentous fungi represents the major way of lovastatin production. However, the current lovastatin productivity by fungal fermentation is limited and needs to be improved. Results In this study, the lovastatin-producing strains of Aspergillus terreus from marine environment were screened, and their lovastatin productions were further improved by genetic engineering. Five strains of A. terreus were isolated from various marine environments. Their secondary metabolites were profiled by metabolomics analysis using Ultra Performance Liquid Chromatography–Mass spectrometry (UPLC–MS) with Global Natural Products Social Molecular Networking (GNPS), revealing that the production of secondary metabolites was variable among different strains. Remarkably, the strain of A. terreus MJ106 could principally biosynthesize the target drug lovastatin, which was confirmed by High Performance Liquid Chromatography (HPLC) and gene expression analysis. By one-factor experiment, lactose was found to be the best carbon source for A. terreus MJ106 to produce lovastatin. To improve the lovastatin titer in A. terreus MJ106, genetic engineering was applied to this strain. Firstly, a series of strong promoters was identified by transcriptomic and green fluorescent protein reporter analysis. Then, three selected strong promoters were used to overexpress the transcription factor gene lovE encoding the major transactivator for lov gene cluster expression. The results revealed that compared to A. terreus MJ106, all lovE over-expression mutants exhibited significantly more production of lovastatin and higher gene expression. One of them, LovE-b19, showed the highest lovastatin productivity at a titer of 1512 mg/L, which represents the highest production level reported in A. terreus. Conclusion Our data suggested that combination of strain screen and genetic engineering represents a powerful tool for improving the productivity of fungal secondary metabolites, which could be adopted for large-scale production of lovastatin in marine-derived A. terreus.

Screening and Genetic Engineering of Marine-Derived Aspergillus Terreus for High-Efficient Production of Lovastatin

Enhanced Single-Step Bioproduction of the Simvastatin Precursor Monacolin J in an Industrial Strain of Aspergillus Terreus by Employing the Evolved Lovastatin Hydrolase

Synthesis of secondary metabolites by lovastatin-producing strain Aspergillus terreus HZ01

Production of Lovastatin by A Self-Resistant Mutant of Aspergillus Terreus

Optimization of process variables for increased production of lovastatin in Aspergillus terreus PU-PCSIR1 and its characterization

Biotransformation of Agricultural Wastes into Lovastatin and Optimization of a Fermentation Process Using Response Surface Methodology (RSM)

Enhanced Lovastatin Production by Solid State Fermentation of Monascus Ruber

Enhancement of Lovastatin Production by Supplementing Polyketide Antibiotics to the Submerged Culture of Aspergillus Terreus

Optimization of lovastatin production from Aspergillus fumigatus

Effects of carbon sources on fungal morphology and lovastatin biosynthesis by submerged cultivation of Aspergillus terreus

Identification of lovastatin production in Aspergillus terreus strain (KF971363.1) and its antifungal role

Evaluating the outcomes of submerged co-cultivation: production of lovastatin and other secondary metabolites by Aspergillus terreus in fungal co-cultures

Application of Aluminum Oxide Nanoparticles in Aspergillus terreus Cultivations: Evaluating the Effects on Lovastatin Production and Fungal Morphology

Effect of Complex Nitrogen Source on Lovastatin Biosynthesis from Aspergillus Terreus

Effect of carbon source on lovastatin biosynthesis in Aspergillus terreus

Multiplex Metabolic Pathway Engineering of Monascus Pilosus Enhances Lovastatin Production.

Heterologous Synthesis of Monacolin J by Reconstructing Its Biosynthetic Gene Cluster in Aspergillus Niger.

Production of lovastatin and itaconic acid by Aspergillus terreus: a comparative perspective

Engineered monoculture and co-culture of methylotrophic yeast for de novo production of monacolin J and lovastatin from methanol.

Performance and mechanism of co-culture of Monascus purpureus, Lacticaseibacillus casei, and Saccharomyces cerevisiae to enhance lovastatin production and lipid-lowering effects

Optimal conditions for the high yield of bioactive asterric acid from marine derived Fungus Aspergillus sp.